European journal of medicinal chemistry

International journal of pharmaceutics

Chemical communications (Cambridge, England)

physiologia plantarum

aids and behavior

annals of agricultural and environmental medicine : aaem

the american journal of case reports

tuberculosis and respiratory diseases

[1] Promoting Tuberculosis Preventive Therapy for People Living with HIV in South Africa: Interventions Hindered by Complicated Clinical Guidelines and Imbalanced Patient-Provider Dynamics.

[2] Comparative analysis of the effectiveness of tuberculosis prophylaxis in patients with HIV/AIDS treated with isoniazid.

[3] Amino acid conjugated antimicrobial drugs: Synthesis, lipophilicity- activity relationship, antibacterial and urease inhibition activity.

[4] Nitric oxide as a signaling molecule in brassinosteroid-mediated virus resistance to Cucumber mosaic virus in Arabidopsis thaliana.

[5] Effectiveness of Intravenous Isoniazid and Ethambutol Administration in Patients with Tuberculosis Meningoencephalitis and HIV Infection.

[6] Treatment of Isoniazid-Resistant Pulmonary Tuberculosis.

[7] A Case of Persistent Air Leak Managed by Selective Left Main Bronchus Intubation in an Infant with Pulmonary Tuberculosis.

[8] avaliação de testes rápidos em microplacas usando indicadores de viabilidade celular para determinação da susceptibilidade de cepas de mycobacterium tuberculosis à isoniazida e rifampicina evaluation of rapid microplate assays using cellular-viability indicators to determine patterns of susceptibility to isoniazid and rifampin in mycobacterium tuberculosis strains

[9] genetic polymorphisms of nat2, cyp2e1 and gst enzymes and the occurrence of antituberculosis drug-induced hepatitis in brazilian tb patients

[10] impairment of hepcidin upregulation by lipopolysaccharide in the interleukin-6 knockout mouse brain

[11] first-line anti-tubercular drug resistance of mycobacterium tuberculosis in iran: a systematic review

[12] etiology and clinical characteristics of pediatric acute pancreatitis in saudi arabia: a 20-year experience from a single tertiary center

[13] Encapsulation of Isoniazid-conjugated Phthalocyanine-In-Cyclodextrin-In-Liposomes Using Heating Method.

[14] Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis

[15] Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis

[16] Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis

[17] Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis

[18] Molecular detection of rifampin, isoniazid, and ofloxacin resistance in Iranian isolates of Mycobacterium tuberculosis by high-resolution melting analysis

[19] Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis

[20] In silico discovery of potential drug molecules to improve the treatment of isoniazid-resistant Mycobacterium tuberculosis

[21] Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women.

[22] Transient electromyographic findings in serotonergic toxicity due to combination of essitalopram and isoniazid

[23] Comparative analysis of the effectiveness of tuberculosis prophylaxis in patients with HIV/AIDS treated with isoniazid.

[24] A patient on RIPE therapy presenting with recurrent isoniazid-associated pleural effusions: a case report

[25] Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old.

[26] Human volunteer, in vitro, and molecular level evaluation of an optimized taste-masked isoniazid-chitosan spray-dried microparticle matrix.

[27] Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data.

[28] Effectiveness of Intravenous Isoniazid and Ethambutol Administration in Patients with Tuberculosis Meningoencephalitis and HIV Infection.

[29] Treatment of Isoniazid-Resistant Pulmonary Tuberculosis.

[30] Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS

[31] The effects of lutein on optic nerve injury induced by ethambutol and isoniazid: an experimental study

[32] Quinolone-isoniazid hybrids: synthesis and preliminary cytotoxicity and anti-tuberculosis evaluation.

[33] Isoniazid derivatives and their anti-tubercular activity.

[34] isoniazid induced lupus presenting as oral mucosal ulcers with pancytopenia

[35] isoniazid induced generalized pustugar drug eruption

[36] development of au-nanoprobes combined with loop-mediated isothermal amplification for detection of isoniazid resistance in mycobacterium tuberculosis

[37] avaliação de testes rápidos em microplacas usando indicadores de viabilidade celular para determinação da susceptibilidade de cepas de mycobacterium tuberculosis à isoniazida e rifampicina evaluation of rapid microplate assays using cellular-viability indicators to determine patterns of susceptibility to isoniazid and rifampin in mycobacterium tuberculosis strains

[38] early therapeutic drug monitoring for isoniazid and rifampin among diabetics with newly diagnosed tuberculosis in virginia, usa

[39] assessment of the isoniazid preventive therapy uptake and associated characteristics: a cross-sectional study

[40] A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa

[41] Safety and Effectiveness of Isoniazid Preventive Therapy in Pregnant Women Living with Human Immunodeficiency Virus on Antiretroviral Therapy: An Observational Study Using Linked Population Data